Personal tools

Coexpression cluster:C2330: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C2330_Fibroblast_Adipocyte_Preadipocyte_mesenchymal_Myoblast_neurofibroma_tenocyte |id=C2330 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C2330_Fibroblast_Adipocyte_Preadipocyte_mesenchymal_Myoblast_neurofibroma_tenocyte
|full_id=C2330_Fibroblast_Adipocyte_Preadipocyte_mesenchymal_Myoblast_neurofibroma_tenocyte
|id=C2330
|id=C2330
|ontology_enrichment_celltype=CL:0000057!6.23e-32!75;CL:0002620!4.13e-30!23;CL:0000055!3.85e-16!180;CL:0000499!1.51e-10!27;CL:0002556!4.85e-09!6;CL:0000219!8.13e-09!390;CL:0000136!1.21e-08!15;CL:0000134!1.87e-08!358;CL:0002334!2.49e-08!12;CL:0002580!4.83e-08!3;CL:0002320!5.20e-08!365;CL:0000135!8.72e-08!3;CL:0000386!8.72e-08!3;CL:0000388!8.72e-08!3;CL:0002615!3.71e-07!3
|ontology_enrichment_disease=DOID:17!8.18e-13!5;DOID:450!8.18e-13!5;DOID:66!8.18e-13!5;DOID:423!8.18e-13!5;DOID:0080000!8.18e-13!5;DOID:11722!8.18e-13!5
|ontology_enrichment_uberon=UBERON:0002097!8.69e-19!40;UBERON:0002199!1.09e-17!45;UBERON:0002416!1.09e-17!45;UBERON:0003102!1.48e-16!95;UBERON:0004457!3.68e-10!12;UBERON:0000042!3.68e-10!12;UBERON:0001758!4.85e-09!6;UBERON:0003672!4.85e-09!6;UBERON:0003688!6.07e-09!6;UBERON:0002358!6.07e-09!6;UBERON:0003684!6.07e-09!6;UBERON:0001178!6.07e-09!6;UBERON:0002384!6.19e-08!375;UBERON:0000043!8.72e-08!3
}}
}}

Revision as of 14:22, 21 May 2012


Full id: C2330_Fibroblast_Adipocyte_Preadipocyte_mesenchymal_Myoblast_neurofibroma_tenocyte



Phase1 CAGE Peaks

Hg19::chr15:33180498..33180522,-p4@FMN1
Hg19::chr15:33180558..33180570,-p9@FMN1
Hg19::chr15:33180622..33180633,-p13@FMN1
Hg19::chr22:48819856..48819861,+p@chr22:48819856..48819861
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
fibroblast6.23e-3275
skin fibroblast4.13e-3023
non-terminally differentiated cell3.85e-16180
stromal cell1.51e-1027
fibroblast of periodontium4.85e-096
motile cell8.13e-09390
fat cell1.21e-0815
mesenchymal cell1.87e-08358
preadipocyte2.49e-0812
preadipocyte of the breast4.83e-083
connective tissue cell5.20e-08365
fibrocyte8.72e-083
attachment cell8.72e-083
tendon cell8.72e-083
adipocyte of omentum tissue3.71e-073
Uber Anatomy
Ontology termp-valuen
skin of body8.69e-1940
integument1.09e-1745
integumental system1.09e-1745
surface structure1.48e-1695
cavity lining3.68e-1012
serous membrane3.68e-1012
periodontium4.85e-096
dentition4.85e-096
omentum6.07e-096
peritoneum6.07e-096
abdominal cavity6.07e-096
visceral peritoneum6.07e-096
connective tissue6.19e-08375
tendon8.72e-083
Disease
Ontology termp-valuen
musculoskeletal system disease8.18e-135
myotonic disease8.18e-135
muscle tissue disease8.18e-135
myopathy8.18e-135
muscular disease8.18e-135
myotonic dystrophy8.18e-135


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.